meitshel

ATRA -long- catalyst play

Long
meitshel Aggiornato   
NASDAQ:ATRA   Atara Biotherapeutics, Inc.
developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).

This is not a financial advice!

Upcoming catalysts 06/30/2024 and 06/30/2025

Block buys recently and passive stakes

Rel. Vol. on 03/08/2024 at 4.32

We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.

Keep an eye on 1.0 / 1.2 / 1.4 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.

SL under 0.5 (very tight)

TPs approx. 2.0 maybe even 5.7

Most info on the chart.

Trade carefully!
Commento:
Atara Biotherapeutics, Inc. Passive Stake (FormSC13G)
Declinazione di responsabilità

Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.